$39.14
3.99% yesterday
Nasdaq, Oct 15, 10:00 pm CET

Phibro Animal Health Corporation Class A Stock price

$39.14
-0.39 0.99% 1M
+22.33 132.84% 6M
+18.14 86.38% YTD
+14.99 62.07% 1Y
+25.12 179.17% 3Y
+20.88 114.35% 5Y
+6.33 19.29% 10Y
+22.14 130.24% 20Y
Nasdaq, Closing price Wed, Oct 15 2025
+1.50 3.99%

Key metrics

Basic
Market capitalization
$1.6b
Enterprise Value
$2.2b
Net debt
$641.7m
Cash
$77.0m
Shares outstanding
40.5m
Valuation (TTM | estimate)
P/E
32.9 | 14.6
P/S
1.2 | 1.1
EV/Sales
1.7 | 1.5
EV/FCF
53.3
P/B
5.6
Dividends
DPS
$0.48
Yield 1Y | 5Y
1.2% | 2.6%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
40.3% | 69.9%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$1.3b | $1.5b
EBITDA
$183.0m | $229.5m
EBIT
$137.4m | $173.6m
Net Income
$48.3m | $108.8m
Free Cash Flow
$41.8m
Growth (TTM | estimate)
Revenue
27.4% | 14.8%
EBITDA
82.3% | 25.5%
EBIT
114.0% | 26.4%
Net Income
1,886.0% | 125.5%
Free Cash Flow
-9.8%
Margin (TTM | estimate)
Gross
31.6%
EBITDA
14.1% | 15.4%
EBIT
10.6%
Net
3.7% | 7.3%
Free Cash Flow
3.2%
Financial Health
Equity Ratio
21.0%
Return on Equity
16.9%
ROCE
12.9%
ROIC
8.9%
Debt/Equity
2.5
More
EPS
$1.2
FCF per Share
$1.0
Short interest
5.1%
Employees
2k
Rev per Employee
$670.0k
Show more

Is Phibro Animal Health Corporation Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Phibro Animal Health Corporation Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Phibro Animal Health Corporation Class A forecast:

1x Buy
11%
4x Hold
44%
4x Sell
44%

Analyst Opinions

9 Analysts have issued a Phibro Animal Health Corporation Class A forecast:

Buy
11%
Hold
44%
Sell
44%

Financial data from Phibro Animal Health Corporation Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,296 1,296
27% 27%
100%
- Direct Costs 887 887
26% 26%
68%
409 409
31% 31%
32%
- Selling and Administrative Expenses 272 272
9% 9%
21%
- Research and Development Expense - -
-
-
183 183
82% 82%
14%
- Depreciation and Amortization 46 46
26% 26%
4%
EBIT (Operating Income) EBIT 137 137
114% 114%
11%
Net Profit 48 48
1,886% 1,886%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Phibro Animal Health Corporation Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Phibro Animal Health Corporation Class A Stock News

Neutral
Business Wire
6 days ago
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC), a global leader in animal health and nutrition, today announced it has entered into a licensing agreement with Lighthouse Pharmaceuticals, Inc. for a novel therapeutic asset targeting periodontal health in companion animals. This agreement grants Phibro exclusive rights to develop, manufacture, and commercialize Li...
Neutral
Seeking Alpha
about one month ago
Phibro Animal Health Corporation (NASDAQ:PAHC ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 12:20 PM EDT Company Participants Glenn David - Chief Financial Officer Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Hi. Good afternoon, everyone.
Neutral
Business Wire
about one month ago
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. Chief Financial Officer, Glenn David will address financial analysts and investors on Tuesday, September 9, 2025, at 12:20 PM ET at the Sheraton New York Times Square Hotel. The live audio presentation will be available on...
More Phibro Animal Health Corporation Class A News

Company Profile

Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment comprises of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment offers production of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Head office United States
CEO Jack Bendheim
Employees 1,940
Founded 1946
Website www.pahc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today